BARRX Medical, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its HALO90 Ablation Catheter for the treatment of Radiation Proctitis (RP) and Gastric Antral Vascular Ectasia (GAVE). Both conditions are diseases of the gastrointestinal tract associated with chronic bleeding and the need for blood transfusions. The HALO90 catheter is used in conjunction with the HALOFLEX and HALO90 Energy Generators during endoscopic procedures to control bleeding in the gastrointestinal tract through the coagulation of affected tissue...![](/proxy.php?image=http%3A%2F%2Ffeedads.g.doubleclick.net%2F%7Ea%2Fam_ccYnCzdIsa2QHcUbLmreumhU%2F0%2Fdi&hash=3755629baf3aa9e21d5f1d2c318aaaea)
![](/proxy.php?image=http%3A%2F%2Ffeedads.g.doubleclick.net%2F%7Ea%2Fam_ccYnCzdIsa2QHcUbLmreumhU%2F1%2Fdi&hash=c9fb7aa66e8da8da7db8905d54f2893d)
More...
More...